Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions
- 325 Downloads
Purpose of Review
The approach to systemic sclerosis (SSc) has changed over the years with an increasing focus on the very early diagnosis of the disease. The terminology identifying patients in the early phase of SSc has been significantly confusing in the last three decades. The purpose of this article is to analyze how the concept of “very early SSc” has evolved over the years, which is the role of an early diagnosis and how early treat patients.
Several attempts have been made over time, to create more sensitive and specific classification criteria to include the largest number of SSc patients, also in the earliest phase. An algorythm for the very early diagnosis of SSc was identified, diagnostic preliminary criteria proposed, and new 2013 ACR/EULAR SSc classification criteria published, including new items and adding emphasis to the vasculopathic manifestations. True biomarkers that could predict the disease evolution are still missing.
Treat or not to treat patients in the earliest phases still remain a dilemma. For the moment, the only feasible clinical strategy in very early SSc remains a tight follow up program to detect in “real time” the early internal organ involvement which may allow an aggressive therapeutic agenda.
KeywordsSystemic sclerosis Early diagnosis Puffy fingers Raynaud phenomenon Classification criteria
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of Particular Interest, Published Recently, Have Been Highlighted as: • Of importance •• Of major importance
- 3.Dinkler M. Zur lehre von der sklerodermie. Dtsch Arch Klin Med. 1981;48:514–77.Google Scholar
- 7.•• Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008;58(3):902–12. This work highlights the progression of patients characterised by RP, ANA positivity and capillaroscopic modifications to definite SSc according to the old ARA criteria (1980). Google Scholar
- 14.Fine LG, Denton CP, Korn J, de Crombrugghe B, Black CM. Systemic sclerosis: current pathogenetic concepts and future prospects for targeted therapies. Lancet. 1996;3(47):1453–8.Google Scholar
- 16.Bellando Randone S, Cutolo M, Czirjak L, Matucci Cerinic M. Mixed connective tissue disease, a roundabout to rheumatic diseases? Curr Rheumatol Rev. 2009;5(2):133–140.Google Scholar
- 25.• Lepri G, Bellando-Randone S, Guiducci S, et al. Esophageal and anorectal involvement in patients with very early diagnosis of systemic sclerosis (VEDOSS): report from a single EUSTAR centre. Ann Rheum Dis. 2015;74(1):124–814. The study provides demonstrate the presence of GI involvement since the very early phases of SSc. CrossRefPubMedGoogle Scholar
- 27.Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma)- Arthritis Rheum 1980; 23:581–90.Google Scholar
- 33.Matucci-Cerinic M, Allanore Y, Czirják L, Tyndall A, Müller-Ladner U, Denton C, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis. 2009;68:1377–80.CrossRefPubMedGoogle Scholar
- 34.•• Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, The EUSTAR co-workers, et al. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis. 2014;73(12):2087–93. The study provides preliminary data demonstrating that puffy fingers may indicate the presence of an underlying SSc. CrossRefPubMedGoogle Scholar
- 35.• Bruni C, Guiducci S, Bellando-Randone S, Lepri G, Braschi F, Fiori G, et al. Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis. Rheumatology (Oxford). 2015;54:72–6. The study showed that digital ulcers are already present since the earliest phases of disease, correlating with gastrointestinal involvement. and may represent a sentinel sign for early organ involvement in VEDOSS patients. CrossRefGoogle Scholar
- 37.•• Trapiella-Martínez L, Díaz-López JB, Caminal-Montero L, Tolosa-Vilella C, Guillén-Del Castillo A, RESCLE Investigators, on Behalf of the Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI) et al. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort. Autoimmun Rev. 2017 Aug;16(8):796–802. The paper classifies retrospetively, the spanish patient of the RESCLE Register. The data confirm that a part of the patients are satisfying the VEDOSS criteria and provides the evidence that this patients need more time to satisfy the ACR EULAR CRITERIA than early patients. Google Scholar
- 39.•• Hoffmann-Vold AM, Gunnarsson R, Garen T, Midtvedt O, Molberg O. Performance of the 2013 American College of Rheumatology/European league against rheumatism classification criteria for systemic sclerosis (SSc) in large, well defined cohorts of SSc and mixed connective tissue disease. J Rheumatol. 2015;42(1):60–3. The article confirms the higher sensitivity of 2013 ACR/EULAR SSc criteria than ACR 1980 criteria in a large and representative group of consecutive patients with SSc. CrossRefPubMedGoogle Scholar
- 43.•• Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, et al. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Ann Rheum Dis. 2017;76(7):1207–18. This paper hihglights, in a real life setting, the utility of immunusuppressants for the tratment pf early SSc (< 3 years). CrossRefPubMedPubMedCentralGoogle Scholar